Skip to main content
American Journal of Public Health logoLink to American Journal of Public Health
. 1994 Feb;84(2):303–304. doi: 10.2105/ajph.84.2.303

A pilot syringe exchange program in Washington, DC.

D Vlahov 1, C Ryan 1, L Solomon 1, S Cohn 1, M R Holt 1, M N Akhter 1
PMCID: PMC1614978  PMID: 8296961

Abstract

The Washington, DC City Council authorized a pilot syringe exchange program to operate for only 60 days at a single drug abuse treatment facility in the District. Only adults on the waiting list for treatment were eligible (n = 467). Of the 33 who enrolled, median duration of drug injection was 18 years. Twenty-seven participants denied needle sharing. Of 209 needles distributed, 69% were returned. Low enrollment might have been due to restrictive entry criteria, inconvenient location, incorrect syringe size, and attitudes of treatment staff. For future efforts to have a public health impact, wider accessibility will be needed.

Full text

PDF
303

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson W. The New York Needle Trial: the politics of public health in the age of AIDS. Am J Public Health. 1991 Nov;81(11):1506–1517. doi: 10.2105/ajph.81.11.1506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brickner P. W., Torres R. A., Barnes M., Newman R. G., Des Jarlais D. C., Whalen D. P., Rogers D. E. Recommendations for control and prevention of human immunodeficiency virus (HIV) infection in intravenous drug users. Ann Intern Med. 1989 May 15;110(10):833–837. doi: 10.7326/0003-4819-110-10-833. [DOI] [PubMed] [Google Scholar]
  3. Christensson B., Ljungberg B. Syringe exchange for prevention of HIV infection in Sweden: practical experiences and community reactions. Int J Addict. 1991 Dec;26(12):1293–1302. doi: 10.3109/10826089109062161. [DOI] [PubMed] [Google Scholar]
  4. Gostin L. The needle-borne HIV epidemic: causes and public health responses. Behav Sci Law. 1991 Summer;9(3):287–304. doi: 10.1002/bsl.2370090306. [DOI] [PubMed] [Google Scholar]
  5. Hagan H., Des Jarlais D. C., Purchase D., Reid T., Friedman S. R. The Tacoma Syringe Exchange. J Addict Dis. 1991;10(4):81–88. doi: 10.1300/J069v10n04_06. [DOI] [PubMed] [Google Scholar]
  6. Kaplan E. H., Heimer R. HIV prevalence among intravenous drug users: model-based estimates from New Haven's legal needle exchange. J Acquir Immune Defic Syndr. 1992;5(2):163–169. [PubMed] [Google Scholar]
  7. Rosenberg P. S., Levy M. E., Brundage J. F., Petersen L. R., Karon J. M., Fears T. R., Gardner L. I., Gail M. H., Goedert J. J., Blattner W. A. Population-based monitoring of an urban HIV/AIDS epidemic. Magnitude and trends in the District of Columbia. JAMA. 1992 Jul 22;268(4):495–503. [PubMed] [Google Scholar]
  8. Stimson G. V. Syringe-exchange programmes for injecting drug users. AIDS. 1989 May;3(5):253–260. doi: 10.1097/00002030-198905000-00001. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES